Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer

By Garcia Agustin  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 49-51

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer

By                          

Oncology Letters, Vol. 2, Iss. 6, 2011-01 ,pp. : 1253-1256

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of mitomycin C and cisplatin in heavily pretreated advanced breast cancer

By Hu Xichun   Guo Haiyi   Zhao Xinmin   Wang Zhonghua   Yang Xinmiao   Liu Xiangjin   Li Jin  

The Chinese-German Journal of Clinical Oncology, Vol. 5, Iss. 6, 2006-12 ,pp. : 442-445

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of UFT and leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer

By Gyldenkerne Niels   Glimelius Bengt   Frödin Jan Erik   Kjaer Mogens   Pfeiffer Per   Hansen Flemming   Keldsen Nina   Sandberg Erik   Jakobsen Anders  

Acta Oncologica, Vol. 43, Iss. 3, 2004-04 ,pp. : 276-279

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)

By Hamaguchi Tetsuya  

Gastric Cancer, Vol. 14, Iss. 3, 2011-08 ,pp. : 226-233

Springer Publishing Company

Access to resources Recommend Favorite